Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)

Clinical trial NCT03715985 · UNKNOWN

Trial details

NCT number: NCT03715985
Sponsor: Herlev Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma, Metastatic Non Small Cell Lung Cancer Metastatic Bladder Urothelial Carcinoma, Metastatic

Start date: 2019-01-28
Primary completion: 2022-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.